Researchers are leveraging AI to improve the complex and costly process of creating new medicines. The technology is being used to help scientists design and develop more effective treatments, which can take years to develop and often result in failure. This approach is particularly useful for biologic medicines, which are made from engineered proteins. By applying AI to this process, scientists hope to increase the chances of successful treatments reaching patients. This development has significant implications for the field of medicine, where the need for innovative treatments continues to grow.
Artificial Intelligence Supports Development of New Medicines
Original source
Read the full story at MIT Tech Review →This is an original summary written by Rouagent News. The reporting belongs to MIT Tech Review. Follow the link for their full article.
